ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMC.GB Crism Therapeutics Corp

11.00
0.00 (0.00%)
13 Dec 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Crism Therapeutics Corp AQSE:AMC.GB Aquis Stock Exchange Ordinary Share VGG042401262
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.00 8.00 14.00 11.00 11.00 11.00 0.00 06:59:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amur Minerals Corporation Second Price Monitoring Extn (3308I)

01/12/2022 4:40pm

UK Regulatory


Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart


From Dec 2021 to Dec 2024

Click Here for more Crism Therapeutics Charts.

TIDMAMC

RNS Number : 3308I

Amur Minerals Corporation

01 December 2022

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APMBLBDDGSGDGDB

(END) Dow Jones Newswires

December 01, 2022 11:40 ET (16:40 GMT)

1 Year Crism Therapeutics Chart

1 Year Crism Therapeutics Chart

1 Month Crism Therapeutics Chart

1 Month Crism Therapeutics Chart